Most recently, in Alzheimer’s disease (AD) studies, GAS5 has been found to be significantly upregulated in disease models and patient samples, where it exacerbates pathogenesis by acting as a ceRNA, sponging miR-23b-3p. This evidence concerns the gene GAS5 and early-onset autosomal dominant Alzheimer disease.